Postgraduate research
As part of our mission to continually improve clinical
trials research we identify high-calibre people as
PhD candidates to progress particular research
questions. These candidates contribute significantly to the
development of our research, and we are proud to support an
increasing number of PhD students.
Current and recent PhD
candidates include:
- Belinda Kiely. The art of oncology: communicating survival
expectancy to patients with cancer
- Michaella Smith. Quality of life and arm symptoms
following axillary surgery for breast cancer
- Deme Karikios. The costs and effectiveness of anticancer
treatments
- Puma Sunderasan. Exploring barriers to radiotherapy
utilisation
- Ru-Dee Ting. Microvascular complications of diabetes
- Kushwin Rajamani. The effects of fenofibrate on various
cell functions
- Jordan Fulcher. Studies of cardiovascular disease and its
treatment
- Hannah Verry. Costs of premature mortality in
Australia
- Emily Callander. The Freedom Poverty Measure: a
multidimensional measure of poverty for Australia
- Chee Lee. Predicting individual survival and the benefits of
treatment for cancer patients
- Lukas Staub. Studies of diagnostic test accuracy and clinical
trials of treatment effectiveness
- Prunella Blinman. Patients' and clinicians' preferences for
chemotherapy: what makes it worthwhile?
- Manjula Schou. Statistical methods addressing biases and
inefficiencies in the design and analysis of clinical
trials
- Annette Kifley. Observed and latent measures for global
health-related quality of life assessment
- Mark Donoghoe. Additive regression modelling for risks and
rates with biostatistical applications
For more information, or to discuss your interest in
becoming a student at the CTC, contact
us.
|
